Two avirulent herpes simplex viruses generate lethal recombinants invivo.

xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns="http://www.w3.org/TR/REC-html40"> Two avirulent herpes simplex viruses generate lethal recombinants in vivo.

Two avirulent herpes simplex viruses generate lethal recombinants in vivo.

FREEDOM OF CHOICE IS NOT FREE

          Vaccination News, A Non-Profit Corporation    

Picks of the Day Archives

All the News (includes Breaking News) - a running tab of everything posted on this website since October 29, 2003

Other archives

Return to Vaccination News Home Page (for best results, right click to "open in new window")

View past & current Scandals (columns by Sandy Gottstein aka Mintz)

Subscribe to Scandals

Search This Site using keywords

click here to download Adobe Reader

 

The many vaccines given our children couldn’t possibly do anything like this, right? - SM

 

 

Two avirulent herpes simplex viruses generate lethal recombinants in vivo.
 Javier,-R-T; Sedarati,-F; Stevens,-J-G
 Science. 1986 Nov 7; 234(4777): 746-8.
While it is widely appreciated that infection with a virulent virus can produce disease in an animal, the ability of a mixture of avirulent viruses to produce disease by means of complementation or recombination in vivo has not been established. In this study, two weakly neuroinvasive herpes simplex virus type 1 (HSV-1) strains were simultaneously inoculated onto the footpads of mice. Many (62%) of the animals that received a 1:1 mixture of the viruses died, whereas the animals that received a similar or 100-fold higher dose of each agent alone survived. Of fourteen viruses isolated from the brains of ten mice that died after receiving the mixture of the two weakly neuroinvasive viruses, eleven were recombinants; three of these recombinants were lethal when reapplied to the footpads of mice. These results show that two avirulent HSV-1 variants may interact in vivo to produce virulent recombinants and a lethal infection. They also suggest that different genetic lesions account for the weakly neuroinvasive character of the HSV-1 strains ANG and KOS after footpad inoculation.
 

©Copyright 2008 by Vaccination News, A Non-Profit Corporation. All Rights Reserved. This content may be copied in full ONLY with copyright, contact, creation, authorship, and information intact (including all links), without specific permission, and ONLY when used in a not-for-profit format. If any other use is desired, permission in writing from Sandy Gottstein is required.

Return to Vaccination News Home Page (for best results, right click to "open in new window")

DISCLAIMER:    All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice.  The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.